Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Institute’s COVID-19 in Cancer Patients Study (NCCAPS)

NIH RePORTER · NIH · N02 · $405,994 · view on reporter.nih.gov ↗

Abstract

Lab will conduct coagulopathy assays for NCI to analyze as part of a correlative science objective in NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study, ClinicalTrials.gov Identifier: NCT04387656 https://clinicaltrials.gov/ct2/show/NCT04387656

Key facts

NIH application ID: 10461598
Project number: 75N91021F00056-0-0-1
Recipient: —
Principal Investigator: EDWARD WONG
Activity code: N02
Funding institute: NIH
Fiscal year: 2021
Award amount: $405,994
Award type: —
Project period: 2021-03-01 → 2022-02-28